Skip to main content

Table 1 Composition of the patient base included in this study

From: Economics of botulinum toxin therapy: influence of the abobotulinumtoxinA package size on the costs of botulinum toxin therapy

Diagnosis

Patients

Dose

number [n]

female [n]

male [n]

age mean ± SD [years]

mean ± SD [MU]

Dystonia

51

29

22

60.3 ± 13.5

499.5 ± 371.4

 Cervical Dystonia

37

23

14

 

610.4 ± 371.4

 Blepharospasm

10

6

4

 

189.0 ± 156.5

 Bruxism

4

0

4

 

250.0 ± 115.5

Spasticity

25

12

15

56.7 ± 14.6

1180.0 ± 574.4

 Arm Spasticity

16

7

9

 

985.0 ± 569.3

 Hemispasticity

6

2

4

 

1341.7 ± 399.3

 Paraspasticity

3

1

2

 

1600.0 ± 624.5

 Tetraspasticity

2

2

0

 

1625.0 ± 671.8

Hemifacial Spasm

3

2

1

65.4 ± 16.0

43.3 ± 22.5

Others

4

4

0

48.1 ± 20.8

600.0 ± 294.4

 Hyperhidrosis

2

2

0

 

500.0 ± 70.7

 Stump Pain

1

1

0

 

300

 Focal Dystonia

1

1

0

 

1000